Neuromyelitis Optica Spectrum Disorder: What’s New in Diagnosis and Management?

0.75 COPE
0.75 ABO MOC
45 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Neuromyelitis Optica Spectrum Disorder: What’s New in Diagnosis and Management?

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

This continuing education activity is provided by Purdue U


Support Statement

This activity is supported by an educational grant from Genentech, Inc.


Target Audience

The intended audience for this activity is neurologists, neuro-ophthalmologists, optometrists, ophthalmologists, and other health care professionals involved in the management of patients with neuromyelitis optica spectrum disorder.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Review the latest understanding of the pathophysiology and burden of neuromyelitis optica spectrum disorder (NMOSD).
  • Assess the diagnostic criteria that aid in the differential diagnosis of NMOSD.
  • Evaluate the latest clinical evidence regarding the efficacy and safety of conventional and emerging therapies for the treatment and prevention of NMOSD episodes.

Activity Chair

Andrew G. Lee, MD
Chairman of Ophthalmology
Blanton Eye Institute
Houston Methodist Hospital
Clinical Professor of Ophthalmology
University of Texas Medical Branch MD Anderson Cancer Center
Adjunct Professor of Ophthalmology
Baylor College of Medicine
Houston, TX
Professor of Ophthalmology, Neurology, and Neurosurgery
Weill Cornell Medical College
New York, NY
Clinical Professor of Ophthalmology
University of Buffalo, SUNY
Buffalo, NY
Adjunct Professor of Ophthalmology
University of Iowa
Iowa City, IA


Faculty

Michael D. DePaolis, OD, FAAO
Associate Professor of Clinical Ophthalmology
Flaum Eye Institute/URMedicine
Rochester, NY

Dean M. Wingerchuk, MD, MSc, FRCP(C)
Professor of Neurology
Chair, Department of Neurology
Mayo Clinic
Phoenix/Scottsdale, AZ


Reviewers

Ashay Bhatwadekar, PhD, RPh
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Purdue University is approved by the Council on Optometric Practitioner Education (COPE) as an administrator/provider of continuing education (CE).

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

This enduring material is COPE-accredited for 0.75 continuing education credits and is approved for one (1) year from the date of original release, November 30, 2020 to November 29, 2021.

COPE ID #: 70320-NO
COPE Event #: 120677

Please consult your state’s Board of Optometry to determine if the CE credit may apply toward your CE requirement for license renewal.

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABOSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning requirements for the American Board of Ophthalmology’s Maintenance of Certification (ABO MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit. Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn MOC credits equivalent to the amount of CME credits claimed for the activity.


How to Participate in This Activity and Obtain CE/CME Credit

To participate in this CE/CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Purdue University will issue a CE Certificate or Vindico Medical Education will issue an AMA PRA Category (1) Credit(s) certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, reviewers, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control.

Activity Chair and Faculty report the following relationship(s)

Michael D. DePaolis, OD, FAAO
No relevant financial relationships to disclose.

Andrew G. Lee, MD
No relevant financial relationships to disclose.

Dean M. Wingerchuk, MD, MSc, FRCP(C)
Consulting Fee: Arcus Medica, Biogen, Celgene, Genentech, MedImmune, Novartis, Reistone, TG Therapeutics, Third Rock Ventures
Contracted Research: Alexion, Terumo BCT

Reviewers report the following relationship(s)

Ashay Bhatwadekar, PhD, RPh
Contracted Research: NIH-National Eye Institute

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Purdue University and Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Purdue University and Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Purdue University and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Purdue University and Vindico Medical Education. Neither Purdue University and Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME/COPE Questions?

Contact us at:
Purdue University: pharmacy-cecr@purdue.edu
Vindico Medical Education: cme@vindicocme.com